Enlivex Therapeutics has successfully raised $212 million to invest in RAIN, a token associated with a blockchain-based prediction market. This strategic move positions RAIN as the firm's primary treasury reserve asset, indicating a strong commitment to innovative financial strategies in the biotech sector.